We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$38.8B
AUM Growth
+$957M
(+2.5%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
18.92%
Holding
4,122
New
310
Increased
2,005
Reduced
1,517
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$140M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$87.2M |
| 3 |
CMCT
Creative Media & Community Trust
CMCT
|
+$51.6M |
| 4 |
HECA
Hedgeye Capital Allocation ETF
HECA
|
+$43.6M |
| 5 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$37.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.4M |
| 2 |
iShares S&P 100 ETF
OEF
|
+$31.2M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$29.4M |
| 4 |
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
|
+$25.4M |
| 5 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$24.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.12% |
| 2 | Financials | 4.47% |
| 3 | Industrials | 3.2% |
| 4 | Consumer Discretionary | 3.13% |
| 5 | Communication Services | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Lexicon Pharmaceuticals
LXRX
$1.05B
| $34K | ﹤0.01% |
21,505
| – | – |
|
3877
CalciMedica
CALC
$19.1M
| $32K | ﹤0.01% |
+60,000
| New | +$122K |
|
3878
Quantum-Si Incorporated
QSI
$182M
| $32K | ﹤0.01% |
41,809
+4,042
| +11% | +$4.19K |
|
3879
Village Farms International
VFF
$307M
| $32K | ﹤0.01% |
+11,248
| New | +$36.5K |
|
3880
Kopin
KOPN
$930M
| $31K | ﹤0.01% |
13,615
-1,436
| -10% | -$3.48K |
|
3881
Clean Energy Fuels
CLNE
$384M
| $30K | ﹤0.01% |
11,984
+70
| +0.6% | +$163 |
|
3882
Fractyl Health
GUTS
$111M
| $29K | ﹤0.01% |
64,000
| – | – |
|
3883
Clover Health Investments
CLOV
$2.41B
| $28K | ﹤0.01% |
16,001
| – | – |
|
|
ZENA
3884
ZenaTech Inc
ZENA
$169M
| $28K | ﹤0.01% |
12,198
+2,000
| +20% | +$6.05K |
|
3885
Cardlytics
CDLX
$24.7M
| $27K | ﹤0.01% |
+2,575
| New | +$25.1K |
|
3886
Hyliion Holdings
HYLN
$694M
| $24K | ﹤0.01% |
13,621
| – | – |
|
|
PLG
3887
Platinum Group Metals
PLG
$196M
| $24K | ﹤0.01% |
13,627
| – | – |
|
3888
MDxHealth
MDXH
$24.1M
| $23K | ﹤0.01% |
10,000
| – | – |
|
3889
Akebia Therapeutics
AKBA
$248M
| $22K | ﹤0.01% |
15,909
| – | – |
|
3890
Cibus
CBUS
$144M
| $22K | ﹤0.01% |
+11,000
| New | +$28.3K |
|
|
CGC
3891
Canopy Growth
CGC
$431M
| $22K | ﹤0.01% |
22,716
+1,592
| +8% | +$1.75K |
|
3892
EVgo
EVGO
$497M
| $22K | ﹤0.01% |
12,523
+1,025
| +9% | +$2.74K |
|
|
WPRT
3893
Westport Fuel Systems
WPRT
$34.6M
| $21K | ﹤0.01% |
11,781
-350
| -3% | -$701 |
|
3894
Oxford Square Capital
OXSQ
$166M
| $20K | ﹤0.01% |
11,063
-8,259
| -43% | -$14.9K |
|
|
NXDR
3895
Nextdoor Holdings
NXDR
$986M
| $19K | ﹤0.01% |
+13,326
| New | +$23.1K |
|
3896
Heron Therapeutics
HRTX
$64.7M
| $18K | ﹤0.01% |
22,297
-4,125
| -16% | -$4.78K |
|
3897
loanDepot
LDI
$298M
| $17K | ﹤0.01% |
11,902
-2,266
| -16% | -$4.66K |
|
3898
Surf Air Mobility
SRFM
$98.2M
| $17K | ﹤0.01% |
14,490
+16
| +0.1% | +$33 |
|
|
CAN
3899
Canaan Creative
CAN
$154M
| $16K | ﹤0.01% |
37,919
-2,201
| -5% | -$1.29K |
|
3900
Flux Power
FLUX
$12.5M
| $16K | ﹤0.01% |
15,000
| – | – |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Cambridge Investment Research Advisors held 4,122 positions worth $38.8B, up 2.5% from $37.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors deployed $1.75B of net new capital in Q1 2026, opening 310 new positions and adding to 2,005 existing holdings. Its largest new stake was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $35.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2026 buy was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
- Cambridge Investment Research Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $140M increase.
- Cambridge Investment Research Advisors's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $35.4M.
- Cambridge Investment Research Advisors fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2026, selling an estimated $7.82M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $38.8B portfolio in Q1 2026.
- Cambridge Investment Research Advisors opened 310 new positions and closed 198 in Q1 2026.
- Cambridge Investment Research Advisors's portfolio value rose 2.5% quarter-over-quarter to $38.8B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.